HCPCS Level IIdrugActive
J7601
Ensifentrine inh 3 mg
BETOS: D1G
Effective: 2025-01-01
Referenced in 2 policies
Description
Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ohtuvayre
Manufacturer
Verona Pharma Inc.
HCPCS Dosage
3 MG
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.